Sage Journals: Discover world-class research

Retricted access

Research article

First published 2023-10

Real-World Efficacy and Safety of PARP Inhibitors in Recurrent Ovarian Cancer Patients With Somatic BRCA and Other Homologous Recombination Gene Mutations

Yifang Eva Pan, Annette Hood, Hiba Ahmad [...]

Annals of Pharmacotherapy

Open access

Review article

First published 2020-12

Update on the Role of Poly (ADP-Ribose) Polymerase Inhibitors in the DNA Repair-Deficient Pancreatic Cancers: A Narrative Review

Anup Kasi, Mohammed Al-Jumayli, Robin Park [...]

Journal of Pancreatic Cancer

Retricted access

Research article

First published 2019-10

Identification of LCN1 as a Potential Biomarker for Breast Cancer by Bioinformatic Analysis

Yuemei Yang, Feng Li, Xueying Luo [...]

DNA and Cell Biology

Open access

Review article

First published 2021

The role of PARP inhibitors in BRCA mutated pancreatic cancer

Jeffrey Chi, Su Yun Chung, Ruwan Parakrama [...]

Therapeutic Advances in Gastroenterology

Retricted access

Review article

First published 2016-9

The Current Status of PARP Inhibitors in Ovarian Cancer

Jennifer McLachlan, Angela George, Susana Banerjee

Tumori Journal

Retricted access

Research article

First published 2024

Is tumour sequencing effective for the identification of germline BRCA1/2 pathogenic variant carriers?

Jacopo Azzollini, Iolanda Capone, Matteo Duca [...]

Tumori Journal

Open access

Case report

First published 2021

Olaparib in hormone receptor-positive,HER2-negative metastatic breast cancer with a somatic BRCA2 mutation

Lee S. Schwartzberg, Lesli A. Kiedrowski

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2018

Rucaparib in ovarian cancer: an update on safety,efficacy and place in therapy

Graziela Z. Dal Molin, Kohei Omatsu, Anil K. Sood [...]

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2024

Double Hit in Clear-Cell Renal Cell Carcinoma With Germline Pathogenic ATM Mutation and Somatic VHL Mutation

Kok Hoe Chan, Nicolas Duque Clavijo, Gustavo Ayala [...]

Journal of Investigative Medicine High Impact Case Reports

Open access

Case report

First published 2025

Immunotherapy With Pembrolizumab for Resectable dMMR/MSI-H Stage III Colon Cancer: A Case of Personalized,Precision Surgery-Sparing Immunotherapy

Stanley Kim, Joseph I. Clark

Journal of Investigative Medicine High Impact Case Reports

Search results